Cme (CME) Other Non-Current Liabilities (2009 - 2026)

Cme (CME) has reported Other Non-Current Liabilities for 18 consecutive years, with $793.8 million the latest figure, recorded in Q2 2026.

• Quarterly Other Non-Current Liabilities rose 10.22% year-over-year to $793.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $793.8 million (up 10.22% YoY) and the FY2025 annual result came in at $734.8 million, up 1.89% from the prior year.
• Other Non-Current Liabilities grew to $793.8 million in Q2 2026 per CME's latest filing, from $733.2 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for CME reached as high as $903.5 million in Q1 2022 and fell as low as $720.2 million in Q2 2025.
• A 5-year average of $789.1 million and a median of $796.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities declined 17.55% — and 2026, when it climbed 10.22%.
• Year by year, Other Non-Current Liabilities stood at $826.0 million in 2022, then declined by 3.37% to $798.2 million in 2023, then slipped by 9.65% to $721.2 million in 2024, then advanced by 1.89% to $734.8 million in 2025, then climbed by 8.03% to $793.8 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $793.8 million, $733.2 million, and $734.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.